News | April 20, 2026
Eli Lilly flags counterfeit Mounjaro seizure in Gurugram
The company said it is supporting the ongoing investigation and reiterated its commitment to patient safety.
The company said it is supporting the ongoing investigation and reiterated its commitment to patient safety.
Genome editing holds extraordinary promise for treating previously incurable genetic diseases
The Clinical Trial Application (CTA) approval clears the way for the company to launch trial locations in France and Romania
ENFLONSIA is a long-acting monoclonal antibody designed to shield infants through a typical five-month RSV season with a single, fixed dose
The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence
Consensus calls for nationwide adoption of potassium-enriched salt to reduce cardiovascular disease risk
Advisory from Apollo Spectra Hospitals highlights hydration, nutrition, and screening as key preventive measures
The company allocated €56 million to research and development for next-generation line solutions
Integrated eCOA technology and rater training aim to reduce variability and strengthen ClinRO outcomes
The study evaluated asundexian (50 mg), a once-daily oral anticoagulant candidate, versus placebo—both given alongside standard antiplatelet therapy
Subscribe To Our Newsletter & Stay Updated
